In 1998, a pharmaceutical company suddenly lost the ability to make their lifesaving HIV drug at one of its production facilities. Then that failure spread to the company’s analy ...
Several classes of anti-HIV drugs interfere with this stage of HIV’s life cycle: nucleoside reverse transcriptase inhibitors and nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside ...
The women who use injectable drugs in Tunisia number in the thousands. Victims of violence, they turn to sex work where they ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...
New developments in anti-HIV therapy encompass several additional routes to blocking the viral replication cycle 2.For instance, Merck's (Whitehouse Station, NJ, USA) Isentress (raltegravir), a ...
Gilead Sciences, US Government Settle Patent Case Over HIV Prevention Drugs By Blake Brittain (Reuters ... and deliver innovative therapeutics to people with life-threatening diseases." ...